Group 1 - The Hong Kong stock market opened significantly higher on November 24, with the innovative drug ETF fund (520700) rising by 1.93% as of 9:52 AM [1] - CITIC Construction Investment Securities indicated that the innovative drug sector is entering an internationalization 2.0 era, with license-out transactions expected to reach a historical high by 2025 and improved efficiency in medical insurance negotiations [1] - The innovative drug ETF fund (520700) tracks the CSI Hong Kong Stock Connect Innovative Drug Index, which is compiled in a more scientific and reasonable manner, focusing on listed companies involved in the research, production, and services of innovative drugs in the Hong Kong market [1] Group 2 - Off-market investors can access opportunities in the innovative drug sector through connection funds (Class A: 023481; Class C: 023482) [1]